Please enable JavaScript to continue using this application.

Compare $CTOR vs $ICCC | Chartloom

Compare

$CTOR vs $ICCC

Citius Oncology Inc · ImmuCell Corp

CTOR

Citius Oncology Inc

ICCC

ImmuCell Corp

Compare $CTOR vs $ICCC

Comparing Citius Oncology Inc and ImmuCell Corp

CTORCitius Oncology Inc

ICCCImmuCell Corp

CTORCitius Oncology Inc

Market cap

$78M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.10x

Rev growth (TTM)

—

YTD performance

-22.2%

52W performance

-54.4%

FCF yield

-24.8%

ICCCImmuCell Corp

Market cap

$89M

P/E (TTM)

114.37x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

8.5%

YTD performance

65.5%

52W performance

48.7%

FCF yield

4.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTOR

ICCC

Detailed metrics comparison

CTOR

Citius Oncology Inc

ICCC

ImmuCell Corp

Market Cap

CTOR$78M

ICCC$89M

Enterprise Value

CTOR$72M

ICCC$88M

Price

CTOR$0.84

ICCC$9.80

P/E Ratio

CTORN/A

ICCC114.37x

P/S Ratio

CTOR10.99x

ICCC2.89x

EV/Sales

CTOR10.10x

ICCC2.87x

EV/EBITDA

CTOR0.00x

ICCC14.10x

P/B Ratio

CTOR2.19x

ICCC2.82x

P/FCF Ratio

CTORN/A

ICCC21.04x

EV/FCF

CTOR-3.70x

ICCC20.91x

PEG Ratio

CTORN/A

ICCCN/A

Forward P/E (NTM)

CTORN/A

ICCCN/A

Forward P/S (NTM)

CTOR1.10x

ICCCN/A

Revenue (TTM)

CTOR$7M

ICCC$31M

Revenue Growth (YoY)

CTORN/A

ICCC8.5%

Forward Rev Growth

CTOR65.4%

ICCC0.0%

Gross Margin (TTM)

CTOR77.3%

ICCC40.3%

Operating Margin (TTM)

CTOR0.0%

ICCC3.9%

EBITDA Margin (TTM)

CTOR-542.8%

ICCC20.4%

Net Margin (TTM)

CTOR-648.3%

ICCC2.6%

FCF Margin (TTM)

CTOR-272.9%

ICCC13.7%

Net Income (TTM)

CTOR$-46M

ICCC$787K

FCF (TTM)

CTOR$-19M

ICCC$4M

EPS (TTM)

CTOR-$0.43

ICCC$0.09

ROE (TTM)

CTOR-10298.0%

ICCC2.7%

ROA (TTM)

CTOR-4349.0%

ICCC1.8%

ROIC (TTM)

CTOR-9188.0%

ICCC2.1%

Cash

CTOR$17M

ICCC$9M

Debt

CTOR$10M

ICCC$8M

Net Cash/Debt

CTOR$6M

ICCC$557K

Current Ratio (TTM)

CTOR0.73x

ICCC4.75x

Quick Ratio (TTM)

CTOR0.29x

ICCC2.65x

Debt/Equity (TTM)

CTOR0.25x

ICCC0.26x

Debt/Assets (TTM)

CTOR0.0%

ICCC0.0%

Interest Coverage (TTM)

CTORN/A

ICCCN/A

Net Debt/EBITDA (TTM)

CTOR0.00x

ICCC0.00x

Beta

CTOR3.34

ICCC0.60

52W Performance

CTOR-54.4%

ICCC48.7%

YTD Performance

CTOR-22.2%

ICCC65.5%

% from 52W High

CTOR-62.7%

ICCC-19.0%

% from 52W Low

CTOR71.0%

ICCC116.8%

Asset Turnover (TTM)

CTOR0.00x

ICCC0.69x

FCF Yield (TTM)

CTOR-24.8%

ICCC4.8%

Earnings Yield (TTM)

CTOR-59.0%

ICCC0.9%

Dividend Yield (TTM)

CTORN/A

ICCCN/A

Rule of 40

CTOR-272.9

ICCC22.2

EV/GP/RG

CTOR0.01

ICCCN/A

Ticker research

View CTOR research View ICCC research

Metric	CTOR Citius Oncology Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$78M	$89M
Enterprise Value	$72M	$88M
Price	$0.84	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	10.99x	2.89x
EV/Sales	10.10x	2.87x
EV/EBITDA	0.00x	14.10x
P/B Ratio	2.19x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-3.70x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.10x	N/A
Revenue & Growth
Revenue (TTM)	$7M	$31M
Revenue Growth (YoY)	N/A	8.5%
Forward Rev Growth	65.4%	0.0%
Profitability
Gross Margin (TTM)	77.3%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	-542.8%	20.4%
Net Margin (TTM)	-648.3%	2.6%
FCF Margin (TTM)	-272.9%	13.7%
Net Income (TTM)	$-46M	$787K
FCF (TTM)	$-19M	$4M
EPS (TTM)	-$0.43	$0.09
ROE (TTM)	-10298.0%	2.7%
ROA (TTM)	-4349.0%	1.8%
ROIC (TTM)	-9188.0%	2.1%
Financial Health
Cash	$17M	$9M
Debt	$10M	$8M
Net Cash/Debt	$6M	$557K
Current Ratio (TTM)	0.73x	4.75x
Quick Ratio (TTM)	0.29x	2.65x
Debt/Equity (TTM)	0.25x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.34	0.60
52W Performance	-54.4%	48.7%
YTD Performance	-22.2%	65.5%
% from 52W High	-62.7%	-19.0%
% from 52W Low	71.0%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.69x
FCF Yield (TTM)	-24.8%	4.8%
Earnings Yield (TTM)	-59.0%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.9	22.2
EV/GP/RG	0.01	N/A
Ticker research	View CTOR research	View ICCC research

Valuation

P/E Ratio

ICCC

114.37x

P/S Ratio

ICCC

2.89x

CTOR

10.99x

EV/FCF

CTOR

-3.70x

ICCC

20.91x

Growth & revenue

Revenue Growth TTM

ICCC

8.5%

Forward Revenue Growth

CTOR

65.4%

ICCC

0.0%

Profitability & performance

Gross Margin

CTOR

77.3%

ICCC

40.3%

ROE

ICCC

2.7%

CTOR

-10298.0%

FCF Yield %

ICCC

4.8%

CTOR

-24.8%

52-Week Performance

ICCC

48.7%

CTOR

-54.4%

Detailed metrics comparison

CTOR

Citius Oncology Inc

ICCC

ImmuCell Corp

Market Cap

CTOR$78M

ICCC$89M

Enterprise Value

CTOR$72M

ICCC$88M

Price

CTOR$0.84

ICCC$9.80

P/E Ratio

CTORN/A

ICCC114.37x

P/S Ratio

CTOR10.99x

ICCC2.89x

EV/Sales

CTOR10.10x

ICCC2.87x

EV/EBITDA

CTOR0.00x

ICCC14.10x

P/B Ratio

CTOR2.19x

ICCC2.82x

P/FCF Ratio

CTORN/A

ICCC21.04x

EV/FCF

CTOR-3.70x

ICCC20.91x

PEG Ratio

CTORN/A

ICCCN/A

Forward P/E (NTM)

CTORN/A

ICCCN/A

Forward P/S (NTM)

CTOR1.10x

ICCCN/A

Revenue (TTM)

CTOR$7M

ICCC$31M

Revenue Growth (YoY)

CTORN/A

ICCC8.5%

Forward Rev Growth

CTOR65.4%

ICCC0.0%

Gross Margin (TTM)

CTOR77.3%

ICCC40.3%

Operating Margin (TTM)

CTOR0.0%

ICCC3.9%

EBITDA Margin (TTM)

CTOR-542.8%

ICCC20.4%

Net Margin (TTM)

CTOR-648.3%

ICCC2.6%

FCF Margin (TTM)

CTOR-272.9%

ICCC13.7%

Net Income (TTM)

CTOR$-46M

ICCC$787K

FCF (TTM)

CTOR$-19M

ICCC$4M

EPS (TTM)

CTOR-$0.43

ICCC$0.09

ROE (TTM)

CTOR-10298.0%

ICCC2.7%

ROA (TTM)

CTOR-4349.0%

ICCC1.8%

ROIC (TTM)

CTOR-9188.0%

ICCC2.1%

Cash

CTOR$17M

ICCC$9M

Debt

CTOR$10M

ICCC$8M

Net Cash/Debt

CTOR$6M

ICCC$557K

Current Ratio (TTM)

CTOR0.73x

ICCC4.75x

Quick Ratio (TTM)

CTOR0.29x

ICCC2.65x

Debt/Equity (TTM)

CTOR0.25x

ICCC0.26x

Debt/Assets (TTM)

CTOR0.0%

ICCC0.0%

Interest Coverage (TTM)

CTORN/A

ICCCN/A

Net Debt/EBITDA (TTM)

CTOR0.00x

ICCC0.00x

Beta

CTOR3.34

ICCC0.60

52W Performance

CTOR-54.4%

ICCC48.7%

YTD Performance

CTOR-22.2%

ICCC65.5%

% from 52W High

CTOR-62.7%

ICCC-19.0%

% from 52W Low

CTOR71.0%

ICCC116.8%

Asset Turnover (TTM)

CTOR0.00x

ICCC0.69x

FCF Yield (TTM)

CTOR-24.8%

ICCC4.8%

Earnings Yield (TTM)

CTOR-59.0%

ICCC0.9%

Dividend Yield (TTM)

CTORN/A

ICCCN/A

Rule of 40

CTOR-272.9

ICCC22.2

EV/GP/RG

CTOR0.01

ICCCN/A

Ticker research

View CTOR research View ICCC research

Metric	CTOR Citius Oncology Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$78M	$89M
Enterprise Value	$72M	$88M
Price	$0.84	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	10.99x	2.89x
EV/Sales	10.10x	2.87x
EV/EBITDA	0.00x	14.10x
P/B Ratio	2.19x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-3.70x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.10x	N/A
Revenue & Growth
Revenue (TTM)	$7M	$31M
Revenue Growth (YoY)	N/A	8.5%
Forward Rev Growth	65.4%	0.0%
Profitability
Gross Margin (TTM)	77.3%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	-542.8%	20.4%
Net Margin (TTM)	-648.3%	2.6%
FCF Margin (TTM)	-272.9%	13.7%
Net Income (TTM)	$-46M	$787K
FCF (TTM)	$-19M	$4M
EPS (TTM)	-$0.43	$0.09
ROE (TTM)	-10298.0%	2.7%
ROA (TTM)	-4349.0%	1.8%
ROIC (TTM)	-9188.0%	2.1%
Financial Health
Cash	$17M	$9M
Debt	$10M	$8M
Net Cash/Debt	$6M	$557K
Current Ratio (TTM)	0.73x	4.75x
Quick Ratio (TTM)	0.29x	2.65x
Debt/Equity (TTM)	0.25x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.34	0.60
52W Performance	-54.4%	48.7%
YTD Performance	-22.2%	65.5%
% from 52W High	-62.7%	-19.0%
% from 52W Low	71.0%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.69x
FCF Yield (TTM)	-24.8%	4.8%
Earnings Yield (TTM)	-59.0%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.9	22.2
EV/GP/RG	0.01	N/A
Ticker research	View CTOR research	View ICCC research